Cho-Hao Lin
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
38
Citations
259
Est. group size
~21
Recurring co-author estimate
Active years
16
Publishing since 2011
Cho-Hao Lin's research focuses on molecular signaling pathways involved in cancer, including studies on drug combination therapies for hepatocellular carcinoma (liver cancer) and related mechanisms in blood cancers like chronic lymphocytic leukemia. The work draws on biochemistry and molecular biology to understand how cell signaling pathways, inflammation markers, and specific proteins contribute to disease progression and potential drug targets. This research area sits within cancer biology and cell signaling, with an emphasis on translational applications such as combination drug treatments.
Publication output has been variable over the past decade with sparse early years, a marked increase starting in 2022-2023, and an anomalous data point suggesting recent growth in activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Ibrutinib in Combination with Sorafenib Synergistically Inhibits Proliferation and Survival of Hepatocellular Carcinoma Cells by Targeting EGFR Signaling Pathway
VCU Scholars Compass (Virginia Commonwealth University) · 2017
- Figshare×18
- Cancer Research×3
- The Journal of Immunology×2
- American Journal Of Pathology×1
- Frontiers in Cell and Developmental Biology×1
- Jinmin Miao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Frederick Nguele Meke
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Jinan Ayub
Biochemistry, Genetics and Molecular Biology · Indiana University
- Darien E. Reed
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Nam Chu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile